¹⁷⁷ Lu-Prostate-Specific Membrane Antigen Neoadjuvant to Stereotactic Ablative Radiotherapy for Oligorecurrent Prostate Cancer (LUNAR): An Open-Label, Randomized, Controlled, Phase II Study

Amar U. Kishan, Jérémie Calais, Holly Wilhalme et al.|Journal of Clinical Oncology|2025

Cited by 24